Cardiogenic Shock: Treatment

Zaza Iakobishvili, David Hasdai*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


The treatment of cardiogenic shock complicating the acute coronary syndromes consists of medical therapy, percutaneous revascularization procedures, cardiac surgery, and the implantation of devices. Medical therapy is limited to different positive inotropic and vasoactive drugs, without any firm evidence of survival benefit using these drugs. Several new pharmacologic compounds are at different stages of clinical research, but are not yet routinely approved for the treatment of cardiogenic shock. The only evidence-based therapy with proven survival benefit is timely revascularization. Intra-aortic balloon pump counterpulsation maintains its central role as supportive treatment in cardiogenic shock patients. Anecdotal evidence is available about the use of ventricular assist devices, cardiac resynchronization therapy, and emergent heart transplantation.

Original languageEnglish
Pages (from-to)713-727
Number of pages15
JournalMedical Clinics of North America
Issue number4
StatePublished - Jul 2007


Dive into the research topics of 'Cardiogenic Shock: Treatment'. Together they form a unique fingerprint.

Cite this